Health Catalyst (NASDAQ:HCAT) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $16.00 price objective on the stock. Other analysts have also recently issued reports about the company. Piper Sandler decreased their price objective on Health Catalyst from $14.00 […]

Leave a Reply

Your email address will not be published.

Previous post Truist Financial Boosts Cathay General Bancorp (NASDAQ:CATY) Price Target to $47.00
Next post DocGo’s (DCGO) “Overweight” Rating Reaffirmed at Cantor Fitzgerald